Austin W. Marxe & David M. Greenhouse’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Austin W. Marxe & David M. Greenhouse’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$3.52M	Hold	300,000	–	–	0.48%	68
2014 Q2	$4.67M	Hold	300,000	–	–	0.59%	55
2014 Q1	$5.9M	Hold	300,000	–	–	0.65%	49
2013 Q4	$5.04M	Sell	300,000 -50,000	-14%	-$621K	0.54%	57
2013 Q3	$4.58M	Buy	+350,000	New	+$4.73M	0.56%	62

Other funds holding FPRX

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Austin W. Marxe & David M. Greenhouse's FPRX Position: Q3 2014 in Review

Austin W. Marxe & David M. Greenhouse held its Five Prime Therapeutics, Inc. (FPRX) position steady in Q3 2014 at 300,000 shares worth $3.52M. The position accounts for 0.48% of the portfolio, ranked #68.

Austin W. Marxe & David M. Greenhouse first reported a position in FPRX in Q3 2013 and has held it in 5 quarters since. The position peaked at $5.9M in Q1 2014. 63 funds tracked by Wall St. Rank hold FPRX as of Q3 2014.

Austin W. Marxe & David M. Greenhouse held 300,000 shares of Five Prime Therapeutics, Inc. worth $3.52M as of Q3 2014.
Austin W. Marxe & David M. Greenhouse left its Five Prime Therapeutics, Inc. share count unchanged in Q3 2014.
Five Prime Therapeutics, Inc. made up 0.48% of Austin W. Marxe & David M. Greenhouse's portfolio in Q3 2014, its #68 holding.
Austin W. Marxe & David M. Greenhouse first reported a position in Five Prime Therapeutics, Inc. in Q3 2013 and has held it in 5 quarters since.
Austin W. Marxe & David M. Greenhouse's Five Prime Therapeutics, Inc. position peaked at $5.9M in Q1 2014.
63 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q3 2014.

Based on Austin W. Marxe & David M. Greenhouse's 13F filing for Q3 2014, filed 14 Nov 2014.